Citation Impact
Citing Papers
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
2019 Science
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression
2016
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
2019
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
2020
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
2015
Tumor angiogenesis: causes, consequences, challenges and opportunities
2019
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
2018
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Combinatorial Cancer Immunotherapies
2016
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Hepatocellular carcinoma
2018 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
PD-L1–PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection
2022
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
2014
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Nasopharyngeal carcinoma
2019 Standout
Hepatocellular carcinoma
2021 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Immunological landscape and immunotherapy of hepatocellular carcinoma
2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
2015
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Next-generation regulatory T cell therapy
2019
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
Bladder cancer
2016 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
2015
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Oncolytic viruses: adenoviruses
2017
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
2018
Neutrophils in cancer: neutral no more
2016 Standout
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
The PI3K Pathway in Human Disease
2017 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Role of immune cells in pancreatic cancer from bench to clinical application
2016
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Regulatory T-Cell-Mediated Suppression of Conventional T-Cells and Dendritic Cells by Different cAMP Intracellular Pathways
2016
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
State of play and clinical prospects of antibody gene transfer
2017
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Taking regulatory T cells into medicine
2021 StandoutNobel
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
2014
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
2017
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Neoantigens in cancer immunotherapy
2015 StandoutScience
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli‐sani cohort and cellular models
2017
Polyphenols and Human Health: The Role of Bioavailability
2021 Standout
Novel Pancreatic Cancer Vaccines Could Unleash the Army Within
2014
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
2015
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Metronomic chemotherapy and immunotherapy in cancer treatment
2017
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Ivan Shevchenko being referenced
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
2014
Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
2018
Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
2013
Extracellular adenosine metabolism in immune cells in melanoma
2014
Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
2015
Cutting Edge: Low-Affinity TCRs Support Regulatory T Cell Function in Autoimmunity
2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
2017
Low‐dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer
2012